Genmab A/SGMABNASDAQ
Loading
Operating cash flow minus capital expenditures
3Y CAGR
+26.8%/yr
vs +60.8%/yr prior
5Y CAGR
+3.7%/yr
Recent acceleration
Acceleration
-34.0pp
Decelerating
Percentile
P93
Near historical high
vs 5Y Ago
1.2x
Modest growth
Streak
1 yr
Consecutive declineStrong
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $7.33B | -3.4% |
| 2024 | $7.58B | +8.3% |
| 2023 | $7.00B | +94.8% |
| 2022 | $3.60B | +81.9% |
| 2021 | $1.98B | -67.7% |
| 2020 | $6.13B | +404.2% |
| 2019 | $1.22B | +126.1% |
| 2018 | $537.42M | -64.2% |
| 2017 | $1.50B | +409.3% |
| 2016 | $294.61M | - |